Thus, the aim of this study was to perform the first analysis of plasma membranes of neutrophils from AATD patients for HVCN1 expression, and to identify proteases involved in altered membrane protein expression of this proton channel. The gene discussed is HVCN1; the disease is alpha 1-antitrypsin deficiency.